Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

All generic drugs are not equal, study finds

Written by | 1 Mar 2025

Generic drugs manufactured in India are linked to significantly more “severe adverse events” for patients who use them than equivalent drugs produced in the United States, a new… read more.

Blood pressure drug could be a safer alternative for treating ADHD symptoms, finds study

Written by | 28 Feb 2025

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the University of Surrey. In a… read more.

Faster drug development with the help of artificial intelligence

Written by | 26 Jan 2025

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in the early phase of drug development – still largely relies… read more.

Psilocybin shows increasing efficacy for treatment of depression

Written by | 22 Sep 2024

Treatment with psilocybin appears to offer long-term antidepressant effects which are comparable to those of standard antidepressant therapy with the SSRI drug escitalopram. Subjects taking psilocybin also reported… read more.

Study finds gaps in mental health care for people with chronic pain

Written by | 2 Aug 2024

A new University of Arizona Health Sciences study found that adults with chronic pain are more likely to experience symptoms of anxiety and depression than people without chronic pain, yet… read more.

Multisite clinical trial will compare three FDA-approved drugs for Rett syndrome treatment

Written by | 5 Feb 2024

Vanderbilt University Medical Center received a $13 million Department of Defense grant to lead a multisite clinical trial that will evaluate repurposed FDA-approved drugs as treatment options for… read more.

Gabapentinoid use appears to raise risk of COPD exacerbation

Written by | 16 Jan 2024

Researchers from a large retrospective study report that, among patients diagnosed with COPD (chronic obstructive pulmonary disease), gabapentinoid use appears to be associated with an increase in the… read more.

Nearly half of oncology drugs approved since 1998 are precision therapies

Written by | 20 Oct 2023

Of the 198 new oncology drugs approved by the U.S. Food and Drug Administration (FDA) between 1998 and 2022, approximately 43% were precision oncology therapies, the use of… read more.

New research may make future design of nanotechnology safer with fewer side effects

Written by | 13 Oct 2023

A new study may offer a strategy that mitigates negative side effects associated with intravenous injection of nanoparticles commonly used in medicine. The study was published today in Nature… read more.

New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants

Written by | 12 Aug 2023

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has demonstrated the safety and tolerability of a new drug treatment designed as… read more.

Specialty drugs accounted for most new product launches in the past decade. Why do we know so little about how clinical studies influence their diffusion?

Written by | 20 Jun 2023

Researchers from McGill University and Ontario Tech University published a new Journal of Marketing article that examines the drivers of specialty drug diffusion. The study, forthcoming in the Journal of Marketing, is titled “Scientific Evidence… read more.

Metformin lowers risk of long COVID

Written by | 10 Jun 2023

Treatment with the diabetes drug metformin immediately after testing positive for the SARS-CoV-2 virus lowers the risk of developing long COVID by 41%. Researchers reported this finding on… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.